Atrium Innovations Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Atrium Innovations Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013390
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Atrium Innovations Inc (Atrium) is a provider of science-based natural health products. The company develops, manufactures and markets nutritional and dietary supplements. Its major products include minerals, vitamins and specialized products such as enzymes and probiotics. Atrium markets its products under brands such as Garden of Life, Klean Athlete, Minami and Orthica, among others. It has partnerships with academic institutes such as Institute of Nutrition and Functional Foods at Laval University; Cleveland Clinic Center for Functional Medicine and other commercial partners. The company also supports research projects at academic centers across the world. The company has manufacturing facilities in the US, Canada, Europe and Argentina. Atrium is headquartered in Quebec, Canada.

Atrium Innovations Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Atrium Innovations Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Permira Funds Completes Acquisition Of Atrium Innovations For US$1.04 Billion 10
Partnerships 13
Atrium Innovations Forms Joint Venture With Fosun Industrial 13
Licensing Agreements 14
Atrium Innovations Enters Into Licensing Agreement With Juvenon 14
Debt Offering 15
Atrium Innovations Completes Bought Deal Public Offering Of Convertible Debentures Due 2018 For US$78.25 Million 15
Atrium Innovations Completes Private Placement Of Convertible Debentures Due 2018 For US$26.08 Million 17
Asset Transactions 18
Vitamin Wagon Acquires Nutraceutical Products Of Garden Of Life 18
Acquisition 19
Atrium Innovations Acquires 70% Stake In Mucos Pharma 19
Atrium Innovations Acquires Enzimas 20
Atrium Innovations Acquires Robert & Fils 21
Atrium Innovations Inc – Key Competitors 22
Atrium Innovations Inc – Key Employees 23
Atrium Innovations Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Joint Venture 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Key Facts 2
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Atrium Innovations Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Atrium Innovations Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Permira Funds Completes Acquisition Of Atrium Innovations For US$1.04 Billion 10
Atrium Innovations Forms Joint Venture With Fosun Industrial 13
Atrium Innovations Enters Into Licensing Agreement With Juvenon 14
Atrium Innovations Completes Bought Deal Public Offering Of Convertible Debentures Due 2018 For US$78.25 Million 15
Atrium Innovations Completes Private Placement Of Convertible Debentures Due 2018 For US$26.08 Million 17
Vitamin Wagon Acquires Nutraceutical Products Of Garden Of Life 18
Atrium Innovations Acquires 70% Stake In Mucos Pharma 19
Atrium Innovations Acquires Enzimas 20
Atrium Innovations Acquires Robert & Fils 21
Atrium Innovations Inc, Key Competitors 22
Atrium Innovations Inc, Key Employees 23
Atrium Innovations Inc, Subsidiaries 24
Atrium Innovations Inc, Joint Venture 25

★海外企業調査レポート[Atrium Innovations Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bio Techne Corp (TECH)-製薬・医療分野:企業M&A・提携分析
    Summary Bio Techne Corp (Bio Techne), develops manufactures and sells biotechnology products and instruments for research and clinical diagnostics. The company provides proteins and antibodies, and related immunoassays and other reagents for research under brands such as R&D Systems, Novus, Biologic …
  • Caribbean Utilities Company, Ltd.:企業の発電所・SWOT分析2018
    Caribbean Utilities Company, Ltd. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Hotels.com LP:企業の戦略・SWOT・財務情報
    Hotels.com LP - Strategy, SWOT and Corporate Finance Report Summary Hotels.com LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • LendingClub Corporation (LC):企業の財務・戦略的SWOT分析
    LendingClub Corporation (LC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • BioDiem Ltd-製薬・医療分野:企業M&A・提携分析
    Summary BioDiem Ltd (BioDiem) is a biotechnology company that focuses on developing and commercializing vaccines and infectious disease therapies. It develops vaccines and novel therapeutic candidates for the treatment of seasonal and pandemic influenza, antimicrobial and antifungal, and retinal dis …
  • Korea Aerospace Industries Ltd:企業の戦略・SWOT・財務分析
    Korea Aerospace Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Korea Aerospace Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Virgin Australia Holdings Limited:企業のM&A・事業提携・投資動向
    Virgin Australia Holdings Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Virgin Australia Holdings Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • DHI Group Inc:企業のM&A・事業提携・投資動向
    DHI Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DHI Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Shionogi & Co Ltd (4507):企業の財務・戦略的SWOT分析
    Shionogi & Co Ltd (4507) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • PT Cikarang Listrindo (POWR):電力:M&Aディール及び事業提携情報
    Summary PT Cikarang Listrindo (Cikarang Listrindo) is a power company that generates and distributes electricity. The company offers services such as 24hours customer hotline, well trained security team, substation maintenance and calibration of kilo watt hour meters. It caters to automobile, electr …
  • Moog Inc (MOG.A):企業の財務・戦略的SWOT分析
    Moog Inc (MOG.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Orezone Gold Corporation:企業の戦略・SWOT・財務情報
    Orezone Gold Corporation - Strategy, SWOT and Corporate Finance Report Summary Orezone Gold Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Penn Virginia Corporation (PVAC):石油・ガス:M&Aディール及び事業提携情報
    Summary Penn Virginia Corp (Penn Virginia) is an independent oil and gas company. It explores, develops, and produces crude oil, Natural gas liquids (NGL), and natural gas. The company’s operations consist primarily of drilling unconventional horizontal development wells and operating producing well …
  • SpiceJet Limited:企業の戦略・SWOT・財務情報
    SpiceJet Limited - Strategy, SWOT and Corporate Finance Report Summary SpiceJet Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Rongsheng Petrochemical Co Ltd (002493):企業の財務・戦略的SWOT分析
    Summary Rongsheng Petrochemical Co Ltd (Rongsheng), a subsidiary of Zhejiang Rongsheng Holding Group Co Ltd is a chemical company that produces and distributes PTA, polyester fiber and chemical products. The company’s products include synthetic fibers and films, synthetic raw material, synthetic res …
  • Citizen Watch Co., Ltd. (7762):企業の財務・戦略的SWOT分析
    Citizen Watch Co., Ltd. (7762) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Nayara Energy Ltd.:企業の戦略・SWOT・財務分析
    Nayara Energy Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nayara Energy Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Viking Therapeutics Inc (VKTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Viking Therapeutics Inc (Viking Therapeutics) is a clinical-stage biopharmaceutical company that develops novel therapies for patients suffering from metabolic and endocrine disorders. The company’s lead clinical program product candidate include VK5211, an orally available, non-steroidal se …
  • PageGroup plc (PAGE):企業の財務・戦略的SWOT分析
    PageGroup plc (PAGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Stanbic Ibtc Holdings Plc
    Stanbic Ibtc Holdings Plc - Strategy, SWOT and Corporate Finance Report Summary Stanbic Ibtc Holdings Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆